Alkermes Plc (ALKS)
34.91
+1.36
(+4.05%)
USD |
NASDAQ |
Feb 06, 16:00
34.88
-0.03
(-0.09%)
After-Hours: 20:00
Alkermes Shareholders Equity (Quarterly) : 1.733B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 98.22M |
| Krystal Biotech, Inc. | 1.138B |
| CorMedix, Inc. | 374.13M |
| Amicus Therapeutics, Inc. | 230.42M |
| Jazz Pharmaceuticals Plc | 3.959B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.330B |
| Total Liabilities (Quarterly) | 596.08M |
| Debt to Equity Ratio | 0.0413 |
| Current Ratio | 3.672 |
| Net Debt Paydown Yield | 1.20% |